PMID- 34678943 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231213 IS - 2305-6304 (Electronic) IS - 2305-6304 (Linking) VI - 9 IP - 10 DP - 2021 Oct 2 TI - Quantitative NanoLC/NSI(+)-HRMS Method for 1,3-Butadiene Induced bis-N7-guanine DNA-DNA Cross-Links in Urine. LID - 10.3390/toxics9100247 [doi] LID - 247 AB - 1,3-Butadiene (BD) is a common environmental and industrial chemical widely used in plastic and rubber manufacturing and also present in cigarette smoke and automobile exhaust. BD is classified as a known human carcinogen based on evidence of carcinogenicity in laboratory animals treated with BD by inhalation and epidemiological studies revealing an increased risk of leukemia and lymphohematopoietic cancers in workers occupationally exposed to BD. Upon exposure via inhalation, BD is bioactivated to several toxic epoxides including 3,4-epoxy-1-butene (EB), 3,4-epoxy-1,2-butanediol (EBD), and 1,2,3,4-diepoxybutane (DEB); these are conjugated with glutathione and excreted as 2-(N-acetyl-L-cystein-S-yl)-1-hydroxybut-3-ene/1-(N-acetyl-L-cystein-S-yl)-2-hydroxybut-3-ene (MHBMA), 4-(N-acetyl-L-cystein-S-yl)-1,2-dihydroxybutane (DHBMA), and 1,4-bis-(N-acetyl-L-cystein-S-yl)butane-2,3-diol (bis-BDMA). Exposure to DEB generates monoalkylated DNA adducts, DNA-DNA crosslinks, and DNA-protein crosslinks, which can cause base substitutions, genomic rearrangements, and large genomic deletions. In this study, we developed a quantitative nanoLC/NSI(+)-HRMS methodology for 1,4-bis-(gua-7-yl)-2,3-butanediol (bis-N7G-BD) adducts in urine (LOD: 0.1 fmol/mL urine, LOQ: 1.0 fmol/mL urine). This novel method was used to quantify bis-N7G-BD in urine of mice treated with 590 +/- 150 ppm BD for 2 weeks (6 h/day, 5 days/week). Bis-N7G-BD was detected in urine of male and female BD-exposed mice (574.6 +/- 206.0 and 571.1 +/- 163.4 pg/mg of creatinine, respectively). In addition, major urinary metabolites of BD, bis-BDMA, MHBMA and DHBMA, were measured in the same samples. Urinary bis-N7G-BD adduct levels correlated with DEB-derived metabolite bis-BDMA (r = 0.80, Pearson correlation), but not with the EB-derived DNA adducts (EB-GII) or EB-derived metabolites MHBMA and DHBMA (r = 0.24, r = 0.14, r = 0.18, respectively, Pearson correlations). Urinary bis-N7G-BD could be employed as a novel non-invasive biomarker of exposure to BD and bioactivation to its most mutagenic metabolite, DEB. This method will be useful for future studies of 1,3-butadiene exposure and metabolism. FAU - Erber, Luke AU - Erber L AUID- ORCID: 0000-0001-5527-5501 AD - Department of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. FAU - Goodman, Samantha AU - Goodman S AD - Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA. FAU - Jokipii Krueger, Caitlin C AU - Jokipii Krueger CC AD - Department of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. FAU - Rusyn, Ivan AU - Rusyn I AD - Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA. FAU - Tretyakova, Natalia AU - Tretyakova N AUID- ORCID: 0000-0002-0621-6860 AD - Department of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. LA - eng GR - R01 CA100670/CA/NCI NIH HHS/United States GR - T32 ES026568/ES/NIEHS NIH HHS/United States GR - 5K12GM119955/GM/NIGMS NIH HHS/United States GR - K12 GM119955/GM/NIGMS NIH HHS/United States GR - R01 ES029911/ES/NIEHS NIH HHS/United States GR - P01 CA138338/CA/NCI NIH HHS/United States PT - Journal Article DEP - 20211002 PL - Switzerland TA - Toxics JT - Toxics JID - 101639637 PMC - PMC8540193 OTO - NOTNLM OT - 1,3-butadiene OT - LC-MS/MS OT - bis-N7G-BD OT - mercapturic acids OT - urinary DNA adducts COIS- The authors declare no conflict of interest. EDAT- 2021/10/23 06:00 MHDA- 2021/10/23 06:01 PMCR- 2021/10/02 CRDT- 2021/10/22 21:02 PHST- 2021/08/19 00:00 [received] PHST- 2021/09/13 00:00 [revised] PHST- 2021/09/28 00:00 [accepted] PHST- 2021/10/22 21:02 [entrez] PHST- 2021/10/23 06:00 [pubmed] PHST- 2021/10/23 06:01 [medline] PHST- 2021/10/02 00:00 [pmc-release] AID - toxics9100247 [pii] AID - toxics-09-00247 [pii] AID - 10.3390/toxics9100247 [doi] PST - epublish SO - Toxics. 2021 Oct 2;9(10):247. doi: 10.3390/toxics9100247.